GA
GMED icon

Geneva Advisors’s Globus Medical GMED Stock Holding History

Geneva Advisors’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$1.51M Buy
45,457
+1,413
+3% +$44.4K 0.03% 284
2017
Q1 		$1.3M Buy
44,044
+2,065
+5% +$56.4K 0.02% 300
2016
Q4 		$1.04M Sell
41,979
-12,481
-23% -$284K 0.02% 331
2016
Q3 		$1.23M Buy
+54,460
New +$1.28M 0.02% 277

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geneva Advisors's GMED Position: Q2 2017 in Review

Geneva Advisors increased its Globus Medical (GMED) stake by 3.2% in Q2 2017, buying an estimated $44.4K and bringing the position to 45,457 shares worth $1.51M. The position accounts for 0.03% of the portfolio, ranked #284.

Geneva Advisors first reported a position in GMED in Q3 2016 and has held it in 4 quarters since. 244 funds tracked by Wall St. Rank hold GMED as of Q2 2017.

  • Geneva Advisors held 45,457 shares of Globus Medical worth $1.51M as of Q2 2017.
  • Geneva Advisors bought 1,413 Globus Medical shares in Q2 2017, an estimated $44.4K.
  • Globus Medical made up 0.03% of Geneva Advisors's portfolio in Q2 2017, its #284 holding.
  • Geneva Advisors first reported a position in Globus Medical in Q3 2016 and has held it in 4 quarters since.
  • 244 funds tracked by Wall St. Rank held Globus Medical as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.